EP
AVNS

Essential Partners’s Avanos Medical AVNS Stock Holding History

Essential Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$622 Sell
25
-2,281
-99% -$53.4K ﹤0.01% 2423
2026
Q1 		$32.3K Buy
2,306
+31
+1% +$418 0.01% 743
2025
Q4 		$25.5K Sell
2,275
-1,415
-38% -$16.2K 0.01% 819
2025
Q3 		$42.7K Buy
3,690
+2,801
+315% +$32.8K 0.01% 639
2025
Q2 		$10.9K Buy
+889
New +$11.2K ﹤0.01% 823

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Essential Partners's AVNS Position: Q2 2026 in Review

Essential Partners reduced its Avanos Medical (AVNS) stake by 99% in Q2 2026, selling an estimated $53.4K and leaving 25 shares worth $622. The position accounts for ﹤0.01% of the portfolio, ranked #2423.

Essential Partners first reported a position in AVNS in Q2 2025 and has held it in 5 quarters since. The position peaked at $42.7K in Q3 2025. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Essential Partners held 25 shares of Avanos Medical worth $622 as of Q2 2026.
  • Essential Partners sold 2,281 Avanos Medical shares in Q2 2026, an estimated $53.4K.
  • Avanos Medical made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2423 holding.
  • Essential Partners first reported a position in Avanos Medical in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Avanos Medical position peaked at $42.7K in Q3 2025.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.